MPX Receives Final Court Approval for Arrangement with iAnthus
January 18, 2019 17:00 ET
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:...
MPX Securityholders Overwhelming Approve Transformational Business Combination with iAnthus
January 15, 2019 18:00 ET
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:...
MPX Announces Acquisition of Remaining Interests in Massachusetts Companies
January 03, 2019 17:00 ET
|
MPX Bioceutical Corporation
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two...
ISS and Glass Lewis Recommend MPX Securityholders Vote in Favour of the Arrangement and MPX Shareholders Vote in Favour of the MPX Continuance and the MPX International Stock Option Plan
January 03, 2019 08:30 ET
|
MPX Bioceutical Corporation
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTC:MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and...
iAnthus and MPX Announce Receipt of Interim Court Order
December 12, 2018 08:56 ET
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX;...
MPX Awarded Four Conditional Retail Dispensary Licenses in Nevada
December 10, 2018 08:41 ET
|
MPX Bioceutical Corporation
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC (“GreenMart NLV”), a subsidiary of MPX, has...
MPX Reports Financial Results for Its Fiscal Second Quarter of 2019
November 29, 2018 16:30 ET
|
MPX Bioceutical Corporation
TORONTO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today reports financial results for its fiscal second quarter for the three...
MPX Expands Maryland Footprint With Opening of Health for Life White Marsh Dispensary
October 29, 2018 16:45 ET
|
MPX Bioceutical Corporation
TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that the Company will open a new Health for Life dispensary in...
iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States
October 18, 2018 09:51 ET
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX;...
MPX Expands Maryland Footprint With Opening of Baltimore Dispensary
October 12, 2018 08:30 ET
|
MPX Bioceutical Corporation
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today announced that it opened its new Health for Life dispensary in Baltimore,...